Real Estate Pune

Laurus Labs' ₹107.8 Cr KRKA Pharma Investment Signals Pune Industrial Growth

By GeoSquare News Desk · Published 2026-10-15

Laurus Labs has infused ₹107.8 crore into KRKA Pharma, retaining its 49% stake in the subsidiary. The capital injection is aimed at supporting operational expansion and strengthening the company's position in the active pharmaceutical ingredients and contract development manufacturing space.

Pharma expansion to drive industrial property demand

Such investments typically translate into additional production lines, quality control labs, clean rooms, and logistics space. For Pune's industrial real estate market, this means sustained demand for pharma-compliant built-to-suit facilities, Grade-A warehousing, and industrial plots in established manufacturing corridors.

What this means for investors

Pune's pharma and bulk drug manufacturing belt remains a key growth driver. Areas such as Chakan, Ranjangaon, and Shirur are likely to see continued interest from occupiers and investors looking at long-term industrial assets. The employment generated by pharma expansion can also support residential demand in nearby catchments.

Property buyers should focus on locations with good connectivity, reliable power and water supply, and proximity to skilled labour. As always, verify project approvals and RERA registration before making any investment decision.